scholarly journals THE ORIGIN, DEVELOPMENT, AND CURRENT STATUS OF THE HEALTH PROFESSION OF AN ADDICTOLOGIST IN THE CZECH REPUBLIC IN THE BROADER CONTEXT OF THE DEVELOPMENT OF THE ADDICTOLOGY FIELD

2021 ◽  
Vol 14 (1) ◽  
pp. 92-101
Author(s):  
Michal Miovský ◽  
J Libra ◽  
A Volfová ◽  
R Gabrhelík ◽  
A Lososová
2021 ◽  
pp. 1-18
Author(s):  
Břetislav Andrlík

The paper focuses on measuring and quantification of the negative externality of noise pollution generated by freight transport in the Slovak Republic and the Czech Republic. The paper describes negative impacts and significance of noise externalities, whereas it is established that noise causes psychological and physiological harm to affected persons. A separate part of the paper is dedicated to the current status of the European legislation dealing with the issues of the negative externality of noise pollution, in particular Directive 2002/49/EC of the European Parliament and of the Council and Communication COM(2008) 435. The actual measurement of the total, average and marginal costs of noise pollution is implemented in line with the defined methodology and using expert studies defined in the paper. The measurement results show that the costs of the negative externality of noise pollution are high in both countries. According to authors’ calculations, the total costs of the negative externality of noise pollution amount to EUR 100.8 mil in the Czech Republic and EUR 16.9 mil in the Slovak Republic. The paper contains a proposal of internalisation of these costs in the form of performance charges applied to operation of heavy goods vehicles.


Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 4514-4514 ◽  
Author(s):  
Jakub Radocha ◽  
Ludek Pour ◽  
Ivan Spicka ◽  
Vlastimil Scudla ◽  
Evzen Gregora ◽  
...  

Abstract Introduction: Collection of valid data in patients with hematologic malignancies remains a challenge. Especially low grade malignancies require long term follow-up and valid high quality data. The RMG registry was established in 2007 and has become one of the flagship projects of the Czech Myeloma group. To date, four parts of the registry are active - module for multiple myeloma (MM), monoclonal gammopathies of undetermined significance (MGUS), AL amyloidosis (ALA) and Waldeströms macroglobulinemia. The later two has been started in 2014. Aim: To analyze current status of the registry in terms of amount of contained data. Methods: All patients must sign a written consent before entering their data into the registry. Data concerning diagnosis, demography, treatment and survival are regularly collected and updated into the registry via online system at https://trials.cba.muni.cz/trialdb2/interface_forms/login_rmg.asp. The data from MGUS patients are retrospective and prospective, data from MM patients are only prospective (since 2007). Registry is regularly monitored and data are validated by an external monitor. Results: There are 22 participating centers as of July 2015 (18 from the Czech Republic and 4 from Slovakia). Data from 4549 patients with MM, 2168 with MGUS, 121 patients with WM and 22 with ALA have been collected. Together 6860 patients have been included in the registry as of July 2015. Median follow-up of MGUS patients is 4 years (0-35 years) and median follow-up for MM patients is 2 years (0-32 years). The huge amount of data allowed publication of treatment results of MM patients treated with bortezomid and thalidomide in the Czech Republic and regular analysis of patients treated with lenalidomide. Novel prognostic models for MGUS progression and asymptomatic myeloma have been created based on registry data (manuscripts submitted). Conclusion: The RMG is one of the largest registries in Europe. Its biggest advantage is collection of validated updated data which can be used to create rapid analyses in order to react to changing myeloma field. It helps us to create new guidelines and serves as a potent research tool. It can be also used to negotiate reimbursement with healthcare insurance companies and government regulatory authorities for novel drugs implementation into treatment standards. Supported by The Ministry of Education, Youth and Sports (Specific university research of the Faculty of Medicine, University of Ostrava) project no. SGS01/LF/2014-2015, by the Moravian-Silesian Region - grant no. MSK 02692/2014/RRC, by the Institutional Development Plan of University of Ostrava in 2015, financial resources are allocated by The Ministry of Education, Youth and Sports. Supported by grant NT14575. Disclosures Hajek: Amgen: Honoraria; Celgene: Consultancy; Janssen: Consultancy.


Author(s):  
Josef Podlaha ◽  
Karel Svoboda ◽  
Eduard Hansli´k

After more than 55 years of activities of the Nuclear Research Institute Rez (NRI) in the nuclear field, there are some obsolete nuclear facilities that shall be decommissioned. NRI is a leading institution in all areas of nuclear R&D in the Czech Republic. NRI has had a dominant position in the nuclear programme since it was established in 1955 as a state-owned research organization and it has developed to its current status. In December 1992, NRI has been transformed into a joint-stock company. The Institute’s activity encompasses nuclear physics, chemistry, nuclear power, experiments at the research reactor and many other topics. Main issues addressed in NRI in the past decades were concentrated on research, development and services provided to the nuclear power plants operating VVER reactors, development of chemical technologies for fuel cycle and irradiation services to research and development in the industrial sector, agriculture, food processing and medicine. The NRI operates two research nuclear reactors, many facilities as a hot cell facility, research laboratories, technology for radioactive waste (RAW) management, radionuclide irradiators, an electron accelerator, etc. The obsolete facilities to be decommissioned comprise various research facilities and facilities for RAW management. Decommissioning of nuclear facilities NRI is the only ongoing decommissioning project in the Czech Republic. Decommissioning started in 2003 and will be finished in 2014. Some facilities have already been successfully decommissioned.


2017 ◽  
Vol 63 (1) ◽  
pp. 59-69 ◽  
Author(s):  
Antun Biloš ◽  
Davorin Turkalj ◽  
Ivan Kelić

AbstractThe purpose of this paper is to determine the current status of mobile device usage and mobile learning adoption in vocational education and training (VET) secondary schools in three European Union countries (Austria, the Czech Republic, and Germany). The research focused on exploring students’ mobile device usage habits, their attitudes toward education in the context of mobile application support, and preferences regarding mobile learning features. The research confirmed a high level of mobile device usage among secondary school students on a daily basis; smartphones and laptops were the most commonly used devices. The vast majority of participants perceived themselves to be advanced mobile device users, but reported a deficit of ICT-assisted mobile learning experience. However, the majority of respondents with prior ICT-assisted education experience described it as a positive or very positive experience. In addition, study participants tended to agree that mobile learning will play a significant role in education in the future. The paper also explored the reported differences among the students in the three countries and suggested several implications for understanding students’ views of mobile learning. The findings provide insights into possibilities of m-learning implementation while creating a framework for m-learning application development in the VET secondary school environment.


10.14311/1706 ◽  
2013 ◽  
Vol 53 (1) ◽  
Author(s):  
René Hudec ◽  
Vojtěch Petráček ◽  
Dalimil Šnita

We describe the current status of the Czech contribution to the ESA LOFT space mission, with emphasis on technical aspects. Expertise available in the Czech Republic will play a positive role in the LOFT project and related developments.


Sign in / Sign up

Export Citation Format

Share Document